Verastem | VSTM - الدين





الدين تغيير تاريخ
AbbVie USD 72.86B 5.36B 2026-03
Alaunos Therapeutics USD 10.99M 5.78M 2023-03
AstraZeneca USD 32.24B 1.68B 2026-06
Curis USD 0 0 2022-06
Cytokinetics USD 1.29B 4.48M 2026-03
Gilead Sciences USD 22.17B 2.76B 2026-03
Incyte USD 38.27M 1.16M 2026-06
Laboratory Of America USD 7.24B 714.6M 2026-03
Novartis USD 49.01B 2.02B 2026-06
Pfizer USD 63.19B 536M 2026-06
Roche Holding CHF 33.03B 1.41B 2025-06
TG Therapeutics USD 754.44M 884K 2026-06
Verastem USD 66.79M 26.7M 2024-09